2024-04-24  5:31:51 PM Chg. -0.28 Volume Bid9:36:09 PM Ask9:36:09 PM Market Capitalization Dividend Y. P/E Ratio
93.98CHF -0.30% 5.02 mill.
Turnover: 472.9 mill.
-Bid Size: 1,034 -Ask Size: 5,430 250.93 bill.CHF 3.19% 22.17

Business description

Nestlé is a science-based Nutrition, Health and Wellness company. The creation of Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences reinforced this strategic direction and focus on helping consumers lead a healthier life through nutritional solutions from food and beverages to life-enhancing scientific products. Responding to increasing consumer needs, Nestlé extended its activities to include the field of specialized, medical skin treatments through the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a broad range of innovative and scientifically-proven products.
 

Management board & Supervisory board

CEO
Mark Schneider
Management board
François-Xavier Roger, Béatrice Guillaume-Grabisch, Bernard Meunier, David Rennie, Greg Behar, Laurent Freixe, Leanne Geale, Magdi Batato, Marco Settembri, Sanjay Bahadur, Stefan Palzer, Steven Wood Presley, Remy Ejel , David Xiqiang Zhang, Lisa Gibby
Supervisory board
Paul Bulcke, Dick Boer, Dinesh Paliwal, Eva Cheng, Hanne Jimenez de Mora, Lindiwe Majele Sibanda, Mark Schneider, Patrick Aebischer, Renato Fassbind, Luca Maestri, Chris Leong, Geraldine Matchett, Rainer Blair, Marie-Gabrielle Ineichen-Fleisch, Pablo Isla
 

Company data

Name: Nestlé SA
Address: Avenue Nestlé 55,Vevey
Phone: +41-21-924-1111
Fax: +41-21-924-4800
E-mail: -
Internet: www.nestle.com/
Industry: Consumer Goods
Sector: Food and Beverage
Sub sector: Food Products
End of financial year: 12-31
Free Float: 96.83%
IPO date: 1905-10-25

Investor relations

Name: Luca Borlini
IR phone: +41 21 924 3509
IR Fax: +41 (21) 924 4800
IR e-mail: ir@nestle.com

Company calendar

CW 17 | 2024-04-25 Interim Report 1st Quarter/3 Months
CW 30 | 2024-07-25 Interim Report 2nd Quarter/6 Months
CW 42 | 2024-10-17 Interim Report 3rd Quarter/9 Months
CW 7 | 2025-02-13 Report 4th Quarter
 

Main Shareholders

Others
 
94.96%
BlackRock, Inc.
 
5.04%